Skip to Content

Join the 'Breast Cancer' group to help and get support from people like you.

Breast Cancer News

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 2 days 11 hours ago by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 2 days 11 hours ago by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. Since 2000, Medicare, the publicly funded insurance program for seniors, has covered routine costs of clinical trial participation. But coverage for patients with private insurance differed by insurer and state, the researchers noted. Under the ACA, or Obamacare, however, private insurers had to cover "standard of care" costs of clinical trial participation as of 2014. For this study, the researchers analyzed more than 2,400 patient referrals to the Clinical Center for Targeted Therapy at ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Votrient, Tarceva, Avastin, Tasigna, Pancreatic Cancer, Sutent, Sprycel, Afinitor, Nexavar, Carboplatin, Stomach Cancer, Cisplatin, Cytoxan

Many Terminal Cancer Patients Remain in Denial

Posted 3 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 3 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Letrozole

'Nipple-Sparing' Mastectomies Don't Raise Odds of Cancer's Return: Study

Posted 3 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – Surgeons performing mastectomies can offer a form of the procedure that allows women to retain the nipple for use in breast reconstruction. Now, a reassuring study finds that this type of mastectomy doesn't raise a woman's risk for breast cancer recurrence. "More women are requesting nipple-sparing mastectomy because of the superior cosmetic results. But doctors don't want to take any chances with breast cancer patients' safety for the sake of cosmetic improvement," explained lead researcher Dr. Barbara Smith. She's a surgical oncologist and director of the breast program at Massachusetts General Hospital in Boston. "Our study, which has one of the longest reported follow-ups after therapeutic nipple-sparing mastectomy in the United States, provides additional support that it's safe to leave the nipple intact during mastectomy with only a few exceptions," she ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

Nerlynx Approved to Help Prevent Breast Cancer's Return

Posted 4 days ago by Drugs.com

TUESDAY, July 18, 2017 – Nerlynx (neratinib) has been approved by the U.S. Food and Drug Administration to help prevent HER2-positive breast cancer from returning. It's the first drug designed to prevent return of HER2-positive breast cancer, a genetic form of the disease that's particularly aggressive and can spread to other parts of the body, the agency said in a news release. The drug is meant for what's known as extended adjuvant therapy – given after initial treatment, to further reduce the risk that cancer will return. Breast cancer is the most common form of cancer in the United States, the FDA said. The disease is projected to be diagnosed in more than 250,000 women this year, and more than 46,000 are likely to die of the disease, according to the U.S. National Cancer Institute. Nerlynx, among a class of drugs designed to block enzymes that fuel cancer-cell growth, was ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Neratinib, Nerlynx

FDA Approves Nerlynx (neratinib) to Reduce the Risk of Breast Cancer Returning

Posted 5 days ago by Drugs.com

July 17, 2017 – The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Nerlynx is indicated for adult patients who have been previously treated with a regimen that includes the drug trastuzumab. “HER2-positive breast cancers are aggressive tumors and can spread to other parts of the body, making adjuvant therapy an important part of the treatment plan,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Now, these patients have an option after ... Read more

Related support groups: Cancer, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Nerlynx, Neratinib

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 12 days ago by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," said study lead author Lauren Wallner, an assistant professor of general medicine and epidemiology at the University of Michigan. "Physicians need to recognize that women involve other people in their treatment decisions," she added in a university news release. "These people represent an important group to provide information about treatment options." For the study, the researchers surveyed about 2,500 women who had ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Breast Cancer, Metastatic, Anastrozole, Letrozole, Zoladex, Evista, Megestrol, Megace, Tasigna, Sprycel, Herceptin

For Holocaust Survivors, Raised Risk of Cancer

Posted 12 days ago by Drugs.com

MONDAY, July 10, 2017 – Holocaust survivors face an increased risk for cancer, a new study finds. The study included more than 152,600 survivors of the World War II genocide who were followed for more than 45 years. The researchers compared whether these survivors received compensation for their suffering and whether they were born in Nazi-occupied countries. Cancer was diagnosed in 22 percent of compensated survivors and 16 percent of the others, the findings showed. Compensated survivors were 6 percent more likely to develop any type of cancer; 12 percent more likely to have colorectal cancer; and 37 percent more likely to have lung cancer. In addition, the investigators found that people born in occupied countries had an 8 percent higher cancer risk. Their risk of colorectal cancer was also 8 percent higher, and their risk of lung cancer was 12 percent higher. Female holocaust ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation

2 of 3 Americans Don't Have 'Advance Directive' for End of Life

Posted 15 days ago by Drugs.com

FRIDAY, July 7, 2017 – Most people don't like talking about dying, especially their own death. But it's important to let your loved ones know how you'd like your medical care handled when your "time" comes. Yet, new research found that two-thirds of American adults haven't completed an advance directive. That's a legal document that outlines a person's wishes if they become incapacitated and can't make their own health care decisions, particularly near the end of life. "Most experts agree that some form of written directives are a key component of advance care planning, and yet rates of completion are low and do not appear to be increasing," said study leader Dr. Katherine Courtright. She is an instructor at the University of Pennsylvania's Palliative and Advanced Illness Research Center. "We need to address common barriers to completing these important documents on a national level, ... Read more

Related support groups: Cancer, Breast Cancer, Ankylosing Spondylitis, Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer - Palliative, Gastric Cancer

Dying May Not Be as Awful an Experience as You Think

Posted 16 days ago by Drugs.com

THURSDAY, July 6, 2017 – Does the very idea of death worry and frighten you? There may be reassurance from a new study that finds those fears might be exaggerated. In fact, the research shows, death is often described as a peaceful, "unexpectedly positive" experience by those who approach it. Death is one of life's guarantees, yet it's something people often avoid talking about, according to study author Kurt Gray. He's an assistant professor at the University of North Carolina at Chapel Hill. "There's almost an unspoken assumption that death is something to be avoided at all costs," Gray said. But his team found that the abstract concept of death may be scarier than the reality. To look at the question, the researchers first searched for blogs by people who were terminally ill with cancer or amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) – diseases where patients ... Read more

Related support groups: Anxiety, Anxiety and Stress, Cancer, Breast Cancer, Agitation, Colorectal Cancer, Breast Cancer, Metastatic, Psychiatric Disorders, Amyotrophic Lateral Sclerosis

Do Blacks, Hispanics Get Low Quality Hospice Care?

Posted 17 days ago by Drugs.com

WEDNESDAY, July 5, 2017 – Hospice quality varies, with blacks and Hispanics often getting less desirable end-of-life care, a new study finds. Researchers surveyed thousands of caregivers whose loved ones died in hospice care. They found that minority patients were more likely to receive care in poorer quality hospices than white patients. They also said that family caregivers of black and Hispanic hospice patients were less likely to receive adequate emotional and religious support. "Our findings highlight the need to ensure that blacks and Hispanics have access to high-quality and culturally competent hospice services," said study lead author Rebecca Anhang Price, a senior policy researcher at the RAND Corp. "This is particularly important as people from these groups increase their use of hospice services," she added in a RAND news release. The report wasn't all bad news for ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Gastric Cancer

FDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer Patients

Posted 17 days ago by Drugs.com

WEDNESDAY, July 5, 2017 – More cancer patients may be able to ward off hair loss during chemotherapy treatment. A cooling cap approved in 2015 for use in breast cancer patients has won expanded approval from the U.S. Food and Drug Administration. The DigniCap Cooling System can now be used for patients with solid tumors, the FDA announced. The computer-controlled cap contains liquid that circulates and cools the scalp, narrowing blood vessels. This reduces how much of the chemotherapy drugs reach hair follicle cells, the FDA said. Cooling also decreases activity of hair follicles and slows cell division. The result: Chemo drugs don't affect them as much, according to the FDA. Hair loss is a common side effect of chemotherapy, especially during treatment of most solid tumor cancers. Hair may fall out all at once, little by little or become thin. It's usually temporary – and upsetting. ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Breast Cancer, Metastatic, Anastrozole, Letrozole, Zoladex, Evista, Megestrol, Megace, Tasigna, Sprycel, Herceptin

Many Women Mistaken on 'Side Effects' of Breast Cancer Drug

Posted 29 Jun 2017 by Drugs.com

THURSDAY, June 29, 2017 – Many women at high risk for breast cancer do not take the drug tamoxifen to prevent the disease, often because they confuse naturally occurring symptoms with side effects from the drug. That's the finding of a new study of nearly 4,000 women tracked for almost five years in the United Kingdom. One U.S. expert in breast cancer care wasn't surprised by the findings. "It is true that many women who take the drug are perimenopausal, and it appears that the symptoms the women experience may have nothing to do with the drug and are rather simply due to age," explained oncologist Dr. Stephanie Bernik. "This was already known by physicians, but it is always helpful to have a scientific report to back up the information you give a patient," said Bernik, who is chief of surgical oncology at Lenox Hill Hospital in New York City. Tamoxifen is used to treat women with any ... Read more

Related support groups: Hot Flashes, Breast Cancer, Menopausal Disorders, Tamoxifen, Postmenopausal Symptoms, Breast Cancer, Metastatic, Atrophic Vaginitis, Perimenopausal Symptoms, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Vaginal Dryness, Tamoxifen Hexal, Nolvadex D, Tamofen, Tamosin, Emblon, Nolvadex, Soltamox, Tamone, Tamoxen

New Microscope Scans Breast Tumors During Surgery

Posted 28 Jun 2017 by Drugs.com

WEDNESDAY, June 28, 2017 – A new microscope could help surgeons remove breast tumors completely, reducing the number of women who must undergo repeat surgeries to remove cancer cells that were missed the first time. The microscope, developed by scientists and engineers at the University of Washington, effectively scans tumors and examines cells in three dimensions in under 30 minutes, researchers report. "Pathologists are currently very limited in how much they can look at on a glass slide," study co-author Adam Glaser, a postdoctoral fellow in the UW Molecular Biophotonics Laboratory, said in a university news release. "If we can give them three-dimensional data, we can give them more information to help improve the accuracy of a patient's diagnosis." When removing a breast tumor, known as a lumpectomy, surgeons attempt to remove the cancer but spare as much healthy tissue as ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Surgical Prophylaxis

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer, Cancer

Related Drug Support Groups

methotrexate, tamoxifen, Arimidex, fluorouracil, Femara, anastrozole, letrozole, Xeloda, Herceptin, view more... Aromasin, Afinitor, Taxol, exemestane, Taxotere, Cytoxan, Faslodex, capecitabine, cyclophosphamide, Ibrance, paclitaxel, Gemzar, doxorubicin, gemcitabine, Adriamycin, Menest, vinblastine, eribulin, docetaxel, everolimus, Durabolin, Abraxane, bevacizumab, Tykerb, Kisqali, Velban, fulvestrant, Perjeta, Deca-Durabolin, Kadcyla, Fareston, Methotrexate LPF Sodium, Ixempra, trastuzumab, Trexall, esterified estrogens, Adrucil, Durabolin 50, Cytadren, pertuzumab, Tamoxifen Hexal, thiotepa, lapatinib, nandrolone, Neosar, Hybolin Decanoate, Halotestin, Hybolin-Improved, Halaven, Docefrez, Tepadina, Estratab, Adriamycin PFS, Androlone-D, Andryl 200, Anabolin LA, Cytoxan Lyophilized, Androxy, aminoglutethimide, fluoxymesterone, Onxol, paclitaxel protein-bound, letrozole / ribociclib, ixabepilone, ado-trastuzumab emtansine, palbociclib, ribociclib, Nolvadex, Soltamox, Nolvadex D, Genox, Tamoxen, Tamosin, Tamofen, Emblon, toremifene, Folex PFS, Adriamycin RDF, Tamone, Thioplex